|
The Scientist: NewsBlog:
Amyloid blockers may be a dead end
Posted by Andrea Gawrylewski [Entry posted at 27th January 2008 06:05 PM GMT]
Rate this article
Return to Top comment: Maybe Maybe not by Aaron McCoy [Comment posted 2008-01-30 21:56:25] amyloid polymers may or may not cause symptoms in alz. patients but you can bet your last grant check that you will find them in the brain and spinal fluid of postmortem ad victims. i have seen some beautiful atomic force microscopy images from researchers at my alma mater. Return to Top comment: To anonymous by null null [Comment posted 2008-01-29 17:04:17] Please refer to "Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses." by Lee et al. (2007) for a recent repudiation to the Amyloid Hypothesis. Here's the NCBI link to the article.
http://www.ncbi.nlm.nih.gov/pubmed/17229880?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Likewise, can you provide any article which proves that amyloids cause AD? I think not. Return to Top comment: Evidence for "Great Hoax"? by anonymous poster [Comment posted 2008-01-28 16:00:35] To null null-
If it has been proven "again and again" that amyloid does not cause Alzheimer's disease please kindly provide the evidence to back up your statements. Return to Top comment: Blocking Amyloid Is, At Best, Treating the Symptom But Not the Disease by null null [Comment posted 2008-01-28 12:55:45] The public and the government need to realize and refute the hypothesis that amyloid proteins are the cause of Alzheimer's Disease, which has been proven to be false, again and again, but persistently used as a great hoax by those who benefit financially and professionally. The Amyloid Hypothesis is nothing less than a huge medical fraud - pure and simple. Return to Top comment: From early AD Diagnosis to new therapy? by Sergio Stagnaro [Comment posted 2008-01-28 05:44:34] In my web resources (http://www.semeioticabiofisica.it) I describe an original biophysical-semeiotic method that is easy to apply at the bed side. This method is also reliable in recognizing Alzheimer's Disease, even in initial and/or symptomless stage (See an appropriate document at the application page of my web site). In such neurodegenerative disorder, in my opinion, we must aim early ?clinical? diagnosis, possibly soon after the disease on-set, or better in the so-called ?pre-pathological? phase (i.e. at the disease ?real? risk). The diagnosis must be necessarily ?clinical?, and GPs (whom these patients visit first) have to recognize the initial or ?pre-pathological? stages. These stages are characterized functionally by modification of Neuronal and Cerebral Evoked Potentials, and nowadays can be assessed at the bed-side by means of Biophysical Semeiotics (see Cerebral Tumour application of the method at http://www.semeioticabiofisica.it). In healthy, from the microcirculatory point of view, during stress test both vasomotility (chaotic-deterministic oscillations of cerebral arterioles) and vasomotion (chaotic-deterministic fluctuations of nutritional capillaries and post-capillary venules) particularly in hippocampus, pre-frontal and parietal cerebral regions are maximally activated. On the contrary, individuals with a family history positive for Alzheimer?s disease (and, of course, in patients in the first stages of the disease) under identical conditions have a particular form of microcirculatory activation, characterized by increased vasomotility and decreased vasomotion. I termed this condition "dissociated type". In brief, the flow- and flux-motion in the cerebral microcirculatory bed appears to be clearly decreased, possible due to the dangerous phenomenon of the so-called "microcirculatory blood-flow centralization". I hope that sucha as clinical method could suggest also a new way in the treatment. Comment on this blog |